Subgroup-specific peptide-based enzyme-linked immunosorbent assays from the G-protein of the ovine and bovine respiratory syncytial virus (RSV), respectively, were used to determine the prevalence of the ovine and bovine subgroup strains of RSV infections in cattle. A total of 1,102 bovine serum samples were obtained from 6 diagnostic laboratories located in the northwestern and the southeastern USA and were tested for antibody to either the bovine or ovine subgroups of RSV. Antibody to viruses from each subgroup was present in samples from each region and all states tested. The Southeast had a higher prevalence of the bovine subgroup strains (69.5%). Then did the Northwest (40.9%). The prevalence of the ovine strain was similar for the two regions (16.7% in the southeast, 14.9% in the northwest). The overall prevalence was 56.6% for the bovine strain and 15.9% for the ovine strain. These results suggest members of the ovine subgroup of RSV circulate in the cattle population but with less frequency than those viruses of the bovine subgroup.
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in human infants and calves. [3] [4] [5] 7, 8, 11 Human RSV (HRSV) strains have been divided into 2 major subgroups (A and B) based on their reactions with monoclonal antibodies. 1 The Gglycoprotein from an ovine RSV (ORSV) strain has been cloned and sequenced, and G-protein base sequence comparisons with a bovine RSV (BRSV) strain supports the existence of 2 subgroups of an ungulate RSV. 3, 19 Results of an RNase protection assay also support the conclusion that 2 ruminant RSV subgroups exist, 1 representing BRSV and 1 representing ORSV isolates. 2 The bovine and caprine isolates tested were closely related based on G-glycoprotein nucleotide sequences suggesting that bovine and caprine RSV may belong to the same unique subgroup and distinct from the subgroup represented by an ovine RSV. 11 Ruminant RSV isolates include BRSV, ORSV, and caprine RSV. These viruses are members of the genus Pneumovirus in the family Paramyxoviridae and are enveloped, single-stranded, nonsegmented, negativesense RNA viruses. 20 The RNA contains 10 genes that are transcribed to 10 unique mRNAs, each of which encodes a unique protein. 4, [10] [11] [12] The fusion (F) protein is broadly cross-reactive among strains, whereas the attachment protein G has been the most variable among viral strains. 11, 20 Considerable progress has been made concerning the nature of interspecies transmission of RSV strains. 18, 25 HRSV has produced mild clinical signs in experimentally infected calves, and BRSV antibodies have been identified in pigs and by subtype-specific enzyme-linked immunosorbent assays (ELISAs) in goats and horses. 14, 17, 18, 25 Sheep have been infected experimentally with BRSV, and calves and deer have been infected experimentally with ORSV. 9, 11, 22 Subgroup-specific ELISAs developed from peptides corresponding to extracellular regions of the respective bovine and ovine G-glycoprotein could be used to evaluate the epidemiology of ruminant RSV strains. 12, 18, 25 The estimates of economic losses due to respiratory tract disease in the US cattle industry may approach $1 billion. 11 BRSV is a major respiratory tract pathogen of cattle and is one of few viruses that can cause acute respiratory disease without significant interaction with other pathogens. 11 Outbreaks of respiratory tract disease associated with BRSV vary in severity, but the impact of the existence of more than 1 subgroup on disease severity remains to be elucidated. 16 Several BRSV vaccines are licensed in the USA, but independent information on the efficacy of these vaccines is lacking. 11 The existence of different RSV antigenic subtypes infecting humans and ruminants escalates the importance of epidemiologic studies that independently monitor infections by these subtypes within each population to allow development of the most effective immunoprophylaxis strategies in each species.
The purpose of this communication is to report the findings of an epidemiologic survey of the prevalence of the ORSV and BRSV subgroup infections in cattle. This is the first step in evaluating the contribution, 
Materials and methods
Reagents. Synthetic RSV peptides representing conserved sequences within the G-glycoprotein of each virus were used as antigens in each assay. 3, 18 The peptides were produced by a commercial laboratory a and designated ORSV (CNI-CEGDSACLSLCQDR) and BRSV (VPCSTCEGNLACLS-LCQ).
Sera. Indirect fluorescent antibody (IFA)-positive anti-bovine RSV serum used in this study was produced in a seronegative neonatal calf. b Positive sera used in the ORSV peptide ELISA was produced in rabbits with the ORSV peptide conjugated to keyhole limpet hemocyanin. The conjugated peptide was produced by a commercial laboratory, c and 50 g in Fruend's incomplete adjuvant was injected into rabbits on days 0, 14, 21, and 28. On day 35, 25 ml of whole blood was collected by jugular venipuncture. Serum was stored at Ϫ70 C until used.
Test sera. Sera from cattle were obtained from diagnostic laboratories d-i located in 2 disparate regions (Northwest and Southeast) of the USA. Sera from the Northwest originated from diagnostic laboratories located in states with a relatively high sheep population (Washington, Colorado, and Wyoming). Sera from the Southeast were acquired from diagnostic laboratories located in states with a relatively low sheep population (Tennessee, Georgia, and North Carolina). 21 Must serum samples had been originally submitted to each laboratory from disease-free animals for brucellosis testing. Samples from Georgia had been submitted from animals with a variety of putative diseases. Test samples were not randomly selected from the bovine population but were used because of availability from each region. All sera tested by ELISA were done in triplicate.
IFA. The IFA procedure was done as previously described. 13 Negative bovine control sera used in this study were identified by this procedure.
BRSV peptide ELISA. The BRSV peptide ELISA was done as described elsewhere, with modifications. 12, 15, 18 The optimum concentration of peptide antigens was determined over the range of 0.075-20 g/ml using negative and positive sera. As a consequence, each well of a 96-well ELISA plate j was coated with 0.125 g of peptide in 100 l of phosphate-buffered saline (PBS, pH 7.2) and incubated overnight at 4 C. The plates were washed 6 times with PBS (200 l/well) containing 0.05% polyoxyethylenesorbitan monolaurate (PBSTW) and were treated with PBSTW (280 l/ well) for 60 min at room temperature. Serum samples diluted 1:40 in PBSTW (100 l) were placed in each well for 60 min at 37 C. After 6 washes with PBSTW, 100 l of a peroxidase-conjugated anti-bovine gamma chain-specific IgG k diluted 1:2,000 in PBSTW was placed in each well at 37 C for 1 hr. After the plates were washed 6 times with PBSTW, o-phenylenediamine dihydrochloride l substrate was placed in each well as instructed by the manufacturer. The optical density (OD) of the solution in each well was determined at 450 nm. m Samples were considered positive by the BRSV ELISA if their OD was greater than the mean OD of the IFA-negative samples plus 3 SDs.
ORSV peptide ELISA. The ORSV peptide ELISA was done as described for the BRSV ELISA, except each well of a 96-well ELISA plates was coated with 0.5 g of peptide diluted in 100 l of PBS (pH 7.2). 12 Prevalence determination. The apparent prevalence of ORSV and BRSV was estimated for the regions sampled. The real prevalence could not be calculated because tests used in the past were incapable of discriminating between ORSV and BRSV antibodies. Furthermore, samples tested were not true random samples.
Prevalence in this study was defined as the number of seropositive animals in a population at a given time divided by the total population sampled. The total population tested was defined as bovine serum samples obtained from diagnostic laboratories from each region. 23 Existing cases were serum samples with an OD in the ELISA test greater than the mean of negative samples plus 3 SDs. The total number of sampled individuals with antibody to each RSV peptide was determined. Prevalence was calculated using the following equation: [number of seropositive animals in the population (seropositive cases): total population tested] ϫ 100.
Results
The presence of specific ovine RSV antibody was detected by peptide ELISA in 175 of 1,102 samples for an overall prevalence of 15.9% in the cattle sampled (Table 1) . A much larger proportion, 624 of 1,102 (56.6%), of the samples were positive for the bovine peptide (Table 1 ). Of the samples tested, 134 of 1,102 (12.2%) had antibody to both peptides, 41 of 1,102 (3.7%) had antibody to the ovine peptide only (Table  1) , and 490 of 1,102 (44.4%) were positive for the bovine peptide only. Of all the animals tested, 437 (39.7%) were negative for RSV antibody. Antibody to the ovine strain was present in 26% of all RSV-positive animals, and antibody to the bovine strain was present in 74% of all RSV-positive animals.
Samples tested from the Southeast had a higher prevalence of antibodies to both the ovine peptide (16.7%) and the bovine peptide (69.5%) then did samples from the Northwest (14.9% and 40.9%, respectively; Table 2 ). Of the 606 Southeastern bovine serum samples, 101 reacted to the ORSV peptide and 421 reacted to the BRSV peptide ( Table 2 ). Of the 101 ORSV-positive samples, 15 reacted only to the ovine peptide, whereas 86 reacted also to the bovine peptide. A much larger number of the 606 samples (335) were positive only to the BRSV peptide. Of the 101 ORSVpositive animals identified from the Southeast, 60 (59%) were from Georgia and only 14 (13.9%) were from North Carolina. Of all cattle sampled in the Southeast, those from Georgia had the highest prevalence of circulating antibody to the ORSV peptide (29.7%), followed by those from Tennessee (13.2%) and those from North Carolina (7.0%; Table 3 ).
The proportion of BRSV-positive animals from each state in the Southeast did not vary as much as did the proportion of ORSV-positive animals. The BRSV antibody prevalence in cattle sampled in North Carolina was 75.0%, that in Georgia was 73.2%, and that in Tennessee was 60.3% (Table 3) .
Of the 496 serum samples from the Northwest, a total of 74 (14.9%) reacted to the ORSV peptide, and only 203 (40.9%) reacted to the BRSV peptide ( Table  2) . Of the cattle sampled in the Northwest, those from Colorado had the highest prevalence (29.5%) of antibody to the ovine peptide, followed by those from Wyoming (14.6%) and Washington (9.5%). Of the 74 ORSV-positive animals, 48 had antibodies to both peptides and 26 had antibodies to the ovine peptide only. Wyoming had 43.2% of the total (74) ORSV-positive animals, followed by Colorado (35.1%) and Washington (25.7%; Table 4 ).
Of the 203 BRSV-positive animals from the Northwest, 155 tested positive to the bovine peptide only. Cattle sampled in Colorado had the highest prevalence (73.1%) of antibody to BRSV, followed by those in Wyoming (35.7%) and those in Washington (34.2%). As with animals positive to BRSV in the southeast, the positive animals from the northwest were relatively evenly distributed among states in this region. Wyoming had 38.4% of the 203 BRSV-positive animals from the Northwest, followed by Washington (33.5%) and Colorado (28.1%; Table 4 ).
Discussion
The prevalence of ORSV in cattle was determined in samples submitted to 6 different diagnostic laboratories located in 2 separate regions of the USA. Ideally, a representative sample is selected by a random procedure in which all individuals have an equal chance of being included in the study. 23 However, because random sampling on such a large scale was beyond the scope of this study, a sample of convenience was used to estimate prevalence.
The overall seroprevalence of RSV in cattle determined in this study agreed with results determined in previous research. 7, 8 The prevalence of serum antibody to BRSV was significantly higher than that of serum antibody to ORSV in cattle from both regions and all states tested. The apparent higher circulation of the bovine strain within the cattle population may be a consequence of host adaptation; the ovine strain may not be as well adapted. Only a single round of viral multiplication is obtained if the F 0 protein is not cleaved by host proteases into the biologically active disulfide-linked smaller proteins (F 1 and F 2 ). 17, 20 Information concerning sequence data of the ORSV F-protein including the cleavage site is lacking. 17 The cleavage of F 0 promotes cell-cell fusion, resulting in multiple rounds of viral replication, and is a key determinant in infectivity and pathogenicity of the virus. 17, 20 If cattle were unable to cleave the F protein efficiently, cow-cow transmission of the ovine strain would be minimal.
Cattle from the Southeast had a significantly higher prevalence of BRSV than did those from the Northwest. This discrepancy may be due to differences in vaccination practices in the 2 regions, differences in producer management practices (e.g., less crowding may result in reduced risk of virus exposure among animals), or sampling errors. The difference in RSV vaccination practices in dairy and beef cattle may have resulted in the variation of BRSV prevalence encountered, if 1 type were selectively overrepresented in the study population.
The seroprevalence of the ORSV strain in cattle was 15 .9% in all animals tested by the peptide ELISA. There was little difference in the seroprevalence of ORSV in cattle between the 2 regions tested, but differences were observed within each region. Of cattle sampled in the Southeast, Georgia had twice the seroprevalence to ORSV of either Tennessee or North Carolina. Current vaccines do not contain strains derived from the ORSV subgroup, and therefore vaccine practices could not have contributed to the number of ORSV seropositive animals. The difference in seroprevalence of ORSV may be due to a biased sample population from Georgia. These samples were from diseased animals, whereas samples from the other 2 states were from apparently healthy animals routinely tested for brucellosis. The animals from Georgia may have had greater contact with sheep, resulting in an increased exposure to ORSV, although North Carolina is reported to have the highest population of sheep in the Southeast. 24 Cattle sampled in Colorado had the highest seroprevalence to ORSV of those cattle tested from the Northwest. These cattle may have had greater contact with sheep and thus may have been at greater risk of exposure to the ovine strain of RSV. Colorado also had the highest percentage of BRSV-positive animals in the Northwest. These animals were either at an increased risk for RSV exposure or were more frequently vaccinated by producers.
Although circulating antibody to ovine RSV was demonstrated in these cattle, many questions concerning the epidemiology of ORSV remain to be answered. The proportion of all bovine serum samples tested that had antibody to the ovine strain of RSV (15.9%) was much smaller than the proportion of samples positive for BRSV (56.6%), which suggests that the ovine strain only occasionally infects cattle and primarily circulates in sheep. It is currently unknown whether this virus circulates in cattle in the absence of sheep or whether only cattle in contact with sheep become infected. The fact that the different bovine populations tested had circulating antibody to the ovine strain of RSV may impact future decisions concerning the control of RSV infection in cattle.
